Neuroprotective effects of AT1 receptor antagonists after experimental ischemic stroke: what is important?

about

Renin-angiotensin system as a potential target for new therapeutic approaches in Parkinson's disease.

P2860

Q46316918-4EA3D77C-76F2-4285-8195-201FF0986030

P2860

Neuroprotective effects of AT1 receptor antagonists after experimental ischemic stroke: what is important?

Item

http://www.wikidata.org/entity/Q48189466

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Neuroprotective effects of AT1 ...... mic stroke: what is important?

@en

Neuroprotective effects of AT1 ...... mic stroke: what is important?

@nl

type

Item

label

Neuroprotective effects of AT1 ...... mic stroke: what is important?

@en

Neuroprotective effects of AT1 ...... mic stroke: what is important?

@nl

prefLabel

Neuroprotective effects of AT1 ...... mic stroke: what is important?

@en

Neuroprotective effects of AT1 ...... mic stroke: what is important?

@nl

P1476

Neuroprotective effects of AT1 ...... mic stroke: what is important?

@en

P2093

Juraj Culman

http://www.w3.org/2001/XMLSchema#string

Kjell Brolund-Spaether

http://www.w3.org/2001/XMLSchema#string

Leonie Brolund

http://www.w3.org/2001/XMLSchema#string

Sven O Schuster

http://www.w3.org/2001/XMLSchema#string

Toni Jacob

http://www.w3.org/2001/XMLSchema#string

Yi Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

Pathobiology of ischaemic stroke: an integrated view

Structure and function of the blood-brain barrier

Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association

The angiotensin II type 1-receptor blocker candesartan increases cerebral blood flow, reduces infarct size, and improves neurologic outcome after transient cerebral ischemia in rats.

Effect of transporter inhibition on the distribution of cefadroxil in rat brain

Active transport of the angiotensin-II antagonist losartan and its main metabolite EXP 3174 across MDCK-MDR1 and caco-2 cell monolayers.

A systematic review of nitric oxide donors and L-arginine in experimental stroke; effects on infarct size and cerebral blood flow.

Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense.

Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases.

Sartan-AT1 receptor interactions: in vitro evidence for insurmountable antagonism and inverse agonism.

P2888

s00210-017-1395-y

P304

949-959

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00210-017-1395-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

390

http://www.w3.org/2001/XMLSchema#string

P50

Ingolf Cascorbi

Peter Gohlke

P577

2017-07-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28669009

http://www.w3.org/2001/XMLSchema#string

Neuroprotective effects of AT1 receptor antagonists after experimental ischemic stroke: what is important?

about

P2860

P2860

Neuroprotective effects of AT1 receptor antagonists after experimental ischemic stroke: what is important?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698